TB-500 Thymosin Beta-4 Research: Actin Dynamics and Cell Migration Studies
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Research Overview
TB-500 is a synthetic peptide corresponding to the actin-binding domain of Thymosin Beta-4 (Ac-LKKTETQ, MW 4963.5 g/mol). This peptide fragment represents the critical actin-sequestering region of the full-length thymosin beta-4 protein and serves as a valuable research tool for investigating cytoskeletal dynamics in vitro. TB-500 is extensively studied in cell-based research systems for its G-actin sequestration activity, cytoskeletal reorganization effects, and cell migration pathway modulation across various cell model systems including endothelial, fibroblast, and smooth muscle cell lines.
Molecular Properties
| Property | Value |
|----------|-------|
| Molecular Formula | C₂₁₂H₃₅₀N₅₆O₇₈S |
| Molecular Weight | 4963.5 g/mol |
| Sequence Fragment | Ac-LKKTETQ (actin-binding domain of Thymosin Beta-4) |
| Peptide Length | 43 amino acids |
| Isoelectric Point | ~4.2 |
G-Actin Sequestration Research
Actin Binding Mechanisms
TB-500 demonstrates high binding affinity for monomeric G-actin through its conserved actin-binding domain. In vitro assays utilizing purified actin systems show that TB-500 forms stable 1:1 complexes with G-actin monomers, effectively preventing their polymerization into F-actin filaments. Fluorescence polarization studies indicate binding constants in the nanomolar range, demonstrating the peptide's strong sequestering capacity. This sequestration activity is mediated through specific interactions between the peptide's actin-binding domain and the nucleotide-binding cleft of G-actin.
Cytoskeletal Dynamics Analysis
Cell-based assays employing fluorescently labeled actin reveal that TB-500 treatment significantly alters the G-actin to F-actin ratio within cellular systems. Time-lapse microscopy studies in cultured cell lines demonstrate rapid reorganization of stress fibers and focal adhesions following peptide exposure. Quantitative analysis of cytoskeletal architecture using phalloidin staining shows decreased F-actin density and altered filament organization patterns, consistent with enhanced G-actin sequestration activity.
Cell Migration Pathway Modulation
Endothelial Cell Model Systems
In endothelial cell cultures, TB-500 influences multiple signaling pathways associated with cell motility and vascular remodeling. Transwell migration assays demonstrate enhanced directional migration in response to chemotactic gradients. The peptide modulates expression of matrix metalloproteinases (MMPs) and their inhibitors, affecting extracellular matrix remodeling capacity. Tube formation assays on Matrigel substrates reveal altered angiogenic sprouting patterns, suggesting involvement in endothelial morphogenesis pathways.
Fibroblast Migration Studies
Wound healing scratch assays in fibroblast cell lines show accelerated gap closure rates following TB-500 treatment. Single-cell tracking experiments reveal increased migration velocity and directional persistence. The peptide influences integrin-mediated adhesion dynamics, as demonstrated by focal adhesion turnover assays using fluorescently tagged focal adhesion proteins. Real-time PCR analysis indicates upregulation of genes associated with cell motility, including those encoding actin-related proteins and migration-promoting factors.
Smooth Muscle Cell Research
In smooth muscle cell models, TB-500 affects contractile apparatus organization and cell migration behavior. Traction force microscopy studies demonstrate altered force generation patterns on deformable substrates. The peptide influences calcium-independent migration mechanisms, as evidenced by migration assays conducted in calcium-free media with EGTA supplementation. Immunofluorescence analysis reveals redistribution of smooth muscle-specific markers and altered expression of contractile proteins.
Signaling Pathway Interactions
Rho Family GTPase Modulation
TB-500 influences the activity of Rho family GTPases, key regulators of cytoskeletal dynamics and cell migration. Pull-down assays using specific effector domains demonstrate altered RhoA, Rac1, and Cdc42 activation states following peptide treatment. These changes correlate with observed modifications in stress fiber formation, lamellipodia extension, and filopodia dynamics in cultured cell systems.
PINCH-ILK-Parvin Complex Interactions
Research indicates that TB-500 may influence the PINCH-ILK-Parvin (PIP) complex, which regulates integrin signaling and cytoskeletal organization. Co-immunoprecipitation studies reveal altered protein-protein interactions within this complex following peptide exposure, suggesting a mechanism for the observed changes in cell adhesion and migration behavior.
Research Summary
TB-500 represents a valuable research tool for investigating actin dynamics and cell migration mechanisms in vitro. Its well-characterized G-actin sequestration activity provides a means to manipulate cytoskeletal organization in controlled experimental systems. The peptide's effects on multiple cell types and signaling pathways make it suitable for diverse research applications, from basic cytoskeletal biology studies to complex migration and morphogenesis investigations. Continued research with TB-500 in cell-based assays contributes to our understanding of actin regulation and its role in fundamental cellular processes.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
